Predictive value of 4th post-operative-day CRP in the early detection of complications after laparoscopic bowel resection for endometriosis.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 18 12 2020
revised: 23 03 2021
accepted: 15 04 2021
pubmed: 20 4 2021
medline: 22 12 2021
entrez: 19 4 2021
Statut: ppublish

Résumé

Post-operative CRP on postoperative day 4 (POD) is used for the early detection of complications after colorectal surgery for cancer, but there is no evidence yet that justifies the use of this marker for bowel resection in case of endometriosis. We retrospectively included 66 consecutive patients who underwent bowel resection for endometriosis (stage 4) in Lille university hospital, France, from August 1, 2015 until January 31, 2017. The composite endpoint of our study included anastomotic leakages, infectious or thrombo-embolic complications, hematomas, bowel stenosis, rectorrhagia, voiding dysfunction, and rehospitalization for related symptoms. CRP on POD 4 presents a satisfying area under the curve of 0.85, for the composite endpoint. A CRP cut off value of 56 mg/L yielded a sensitivity of 0.61 (IC95%: 0.36 to 0.83) and a specificity of 0.98 (IC95%: 0.89 to 1). The negative and positive predictive values were 0.87 and 0.92. The negative predictive value of the CRP on POD 4 after bowel resection for endometriosis is a useful early indicator for detecting a complication. Therefore, this biomarker might be safely used as an additional criterion for a safe discharge from hospital after colorectal resection in endometriosis.

Identifiants

pubmed: 33872816
pii: S2468-7847(21)00086-6
doi: 10.1016/j.jogoh.2021.102148
pii:
doi:

Substances chimiques

CRP protein, human 0
Receptors, Immunologic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102148

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All the authors certify they have no conflict of interest about this topic that could influence or bias the work.

Auteurs

Océane Pécheux (O)

Douai hospital, Route de Cambrai - BP 10740 F-59507 Douai Cedex, France. Electronic address: oceane-pecheux@hotmail.fr.

Pauline Dilé (P)

Centre Hospitalier Régional Universitaire de Lille, Hôpital Jeanne de Flandre, 2 avenue Oscar Lambret 59000 Lille, France.

Yohan Kerbage (Y)

Centre Hospitalier Régional Universitaire de Lille, Hôpital Jeanne de Flandre, 2 avenue Oscar Lambret 59000 Lille, France.

Guillaume Piessen (G)

Centre Hospitalier Régional Universitaire de Lille, Hôpital Jeanne de Flandre, 2 avenue Oscar Lambret 59000 Lille, France; Université Lille CHRU Lille F-59000 Lille, France.

Valérie Deken (V)

Department of Biostatistics, Univ. Lille, CHRU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000 Lille, France.

Pierre Collinet (P)

Centre Hospitalier Régional Universitaire de Lille, Hôpital Jeanne de Flandre, 2 avenue Oscar Lambret 59000 Lille, France; Université Lille CHRU Lille F-59000 Lille, France.

Chrystèle Rubod (C)

Centre Hospitalier Régional Universitaire de Lille, Hôpital Jeanne de Flandre, 2 avenue Oscar Lambret 59000 Lille, France; Université Lille CHRU Lille F-59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH